Role of the splicing factor SRSF4 in cisplatininduced modifications of pre-mRNA splicing and apoptosis

Modification of splicing by chemotherapeutic drugs has usually been evaluated on a limited number of pre-mRNAs selected for their recognized or potential importance in cell proliferation or apoptosis. However, the pathways linking splicing alterations to the efficiency of cancer therapy remain unclear.